Reports Q1 revenue $254.523M, consensus $245.79M. “We are pleased to report a solid start to the year with mid-single digit revenue growth and strong double digit Adjusted EBITDA growth, on a constant currency basis,” said Chairman and Chief Executive Officer, Michael Petras, Jr. “We have consistently demonstrated the ability to sustain growth and navigate challenges through varying market conditions. Today we are reaffirming our 2025 outlook as our team remains steadfast in our mission of Safeguarding Global Health.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHC:
- Becton Dickinson price target lowered to $260 from $280 at Piper Sandler
- Sotera Health price target lowered to $13 from $15 at Piper Sandler
- Sotera Health price target lowered to $12 from $16 at Barclays
- Sotera Health Settles Ethylene Oxide Claims for $30.9M
- Sotera’s Nelson Labs launches rapid sterility testing to expedite results